tiprankstipranks
Trending News
More News >
Mersana Therapeutics Inc (MRSN)
NASDAQ:MRSN
US Market
Advertisement

Mersana Therapeutics (MRSN) Income Statement

Compare
660 Followers

Mersana Therapeutics Income Statement

Last quarter (Q2 2025), Mersana Therapeutics's total revenue was $3.06M, an increase of 33.28% from the same quarter last year. In Q2, Mersana Therapeutics's net income was $-24.30M. See Mersana Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 40.50M$ 36.85M$ 26.58M$ 43.00K$ 828.00K
Gross Profit
$ 38.87M$ -111.41M$ 25.65M$ -131.97M$ -66.21M
Operating Expenses
$ 113.83M$ 36.85M$ 230.35M$ 168.90M$ 88.94M
Depreciation and Amortization
$ 1.63M$ 1.52M$ 927.00K$ 855.00K$ 1.01M
EBITDA
$ -63.27M$ -166.08M$ -199.96M$ -167.94M$ -86.68M
Operating Income
$ -73.34M$ -170.96M$ -204.69M$ -169.71M$ -87.69M
Other Income/Expenses
$ 4.56M$ -713.00K$ -445.00K$ -1.20M$ 65.00K
Pretax Income
$ -68.77M$ -171.67M$ -204.21M$ -170.06M$ -88.05M
Net Income
$ -69.19M$ -171.67M$ -207.54M$ -169.21M$ -88.40M
Per Share Metrics
Basic EPS
$ -14.12$ -36.96$ -54.51$ -60.00$ -35.80
Diluted EPS
$ -14.12$ -36.96$ -54.51$ -60.00$ -35.80
Weighted Average Shares Outstanding
4.90M----
Weighted Average Shares Outstanding (Diluted)
4.90M----
Currency in USD

Mersana Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis